Notably, obese CRC patients showcased markedly lower IGF1 levels (P < 0.0001) and considerably higher IGFBP3 levels (P = 0.0018) than levels in the non-obese CRC subgroup. This evidence concerns the gene IGFBP3 and colorectal carcinoma.